Variability in vitamin D assays impairs clinical assessment of vitamin D status

Internal Medicine Journal

Volumn 42, Issue 1, 2012, Pages 43-50

  Lai, J K C ^a   Lucas, R M ^a   Banks, E ^a   Ponsonby, A L ^b  

^a The Australian National University   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

25(OH)D; Measurement; Variability; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CALCIFEDIOL;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; COMPARATIVE STUDY; DEMYELINATING DISEASE; HEALTH STATUS; HUMAN; IMMUNOASSAY; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ARTIFACTS; AUSTRALIA; CALIBRATION; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; DECISION MAKING; DIAGNOSTIC ERRORS; HUMANS; IMMUNOASSAY; LABORATORIES; MASS SPECTROMETRY; OSTEOMALACIA; RADIOISOTOPE DILUTION TECHNIQUE; REPRODUCIBILITY OF RESULTS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84856271521     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2011.02471.x     Document Type: Article

References (25)

1. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 281-5.
2. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008; 149: 404-15.
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
4. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE etal. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int 2010; 21: 1151-4.
5. IARC. Vitamin D and Cancer. Vitamin D and Cancer, Working Group Reports Volume 5. Lyon: World Health Organisation International Agency for Research on Cancer; 2008.
6. Vitamin D External Quality Assessment Scheme (DEQAS). 25 Hydroxyvitamin D October 2009 Distribution 2009.
7. Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr 2008; 87: 1087S-91S.
8. de la Hunty A, Wallace AM, Gibson S, Viljakainen H, Lamberg-Allardt C, Ashwell M. UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr 2010; 104: 612-19.
9. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE etal. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab 2004; 89: 3152-7.
10. Glendenning P, Taranto M, Noble JM, Musk AA, Hammond C, Goldswain PR etal. Current assays overestimate 25-hydroxyvitamin D-3 and underestimate 25-hydroxyvitamin D-2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays. Ann Clin Biochem 2006; 43: 23-30.
11. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008; 45: 153-9.
12. Harrison SL, Nowak M, Buettner PG, Kimlin MG, Porter D, Kennedy RL etal. Public health and clinical dilemmas resulting from imprecise vitamin D tests. J Rural Trop Public Health 2009; 8: 52-8.
13. Lucas RM, Ponsonby AL, McMichael AJ, van der Mei I, Chapman C, Coulthard A etal. Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function. Mult Scler 2007; 13: 827-39.
14. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin Chem 2005; 51: 1683-90.
15. Fleiss JI. Statistical Methods for Rates and Proportions, 2nd edn. New York: John Wiley & Sons Inc; 1981.
16. Carter GD, Carter CR, Gunter E, Jones J, Jones G, Makin HL etal. Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol 2004; 89-90: 467-71.
17. Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 2009; 46: 79-81.
18. Carter GD. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem 2009; 55: 1300-2.
19. Binkley N, Krueger D, Gemar D, Drezner MK. Correlation among 25-hydroxy-vitamin D assays. J Clin Endocrinol Metab 2008; 93: 1804-8.
20. Cavalier E, Rozet E, Gadisseur R, Carlisi A, Monge M, Chapelle JP etal. Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs. Osteoporos Int 2010; 21: 1047-51.
21. Lai JK, Lucas RM, Clements MS, Harrison SL, Banks E. Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res 2010; 54: 1062-71.
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-10.
23. Medicare Australia. Statistical Reports for Item 66608: Vitamin D or D Fractions. Canberra: Australian Government; 2010.
24. Lucas RM, Ponsonby A-L, Dear K, Valery PC, Pender MP, Taylor BV etal. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76: 540-8. (in press).
25. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 2008; 88: 511S-12S.